NCI OA Special Notice of Subcontract Opportunity at the Frederick National Laboratory for Cancer Research
Closed Special Notice Posted
- Agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
This Special Notice (S26-117) was published by the National Cancer Institute on January 26, 2026, regarding subcontracting opportunities at the Frederick National Laboratory for Cancer Research (FNLCR), a Government-Owned Contractor-Operated Federally Funded Research and Development Center located at Fort Detrick, Maryland. Leidos Biomedical Research, Inc., the current operator of FNLCR under prime contracts with the National Cancer Institute, is seeking qualified vendors to provide digital solutions. This Special Notice is informational in nature and does not constitute a formal solicitation; any responses submitted do not constitute binding offers and cannot form contracts with the U.S. Government. The notice is intended to publicize FNLCR's requirements and encourage potential contractors to express interest in upcoming opportunities.
Leidos Biomed is soliciting proposals for the Receiving Process Improvement and Digital Transformation project, which aims to modernize current receiving dock and materials management operations across three FNLCR locations. The scope of work includes assessment of existing processes, design and installation of software solutions with mobile barcode scanning and integration capabilities, end-user training, and go-live support services. Questions from interested vendors must be submitted by 4 PM EST on February 12, 2026, while formal proposal submissions are due by 4 PM EST on March 5, 2026, with a 120-day offer validity period required. The contract will be firm-fixed-price with evaluation criteria prioritizing technical approach (40 percent), team qualifications (25 percent), past performance (10 percent), project planning (10 percent), management (5 percent), and cost reasonableness (10 percent). Cloud-based solutions must achieve FedRAMP compliance, while on-premises solutions require SAM.GOV compliance. Interested parties should contact Cody Wenner at cody.wenner@nih.gov to obtain the full RFP document and monitor https://frederick.cancer.gov/workwithus/solicitations for additional opportunities.
Notice text
This Special Notice is not a formal Invitation for Bid (IFB), Request for Proposal (RFP), Request for Quotation (RFQ) nor any type of Solicitation for offers. In accordance with FAR 15.201(d), this Special Notice is intended FOR INFORMATIONAL PURPOSES ONLY in order to publicize the requirements of the Frederick National Laboratory for Cancer Research (FNLCR).
The FNLCR is a Government-Owned Contractor-Operated Federally Funded Research and Development Center (FFRDC) located at Fort Detrick, Maryland. The FNLCR partners with university, Government, and corporate scientists to speed the translation of laboratory research into new diagnostic tests and treatments for cancer and AIDS. FNLCR is a multi-program laboratory currently operated by Leidos Biomedical Research, Inc. (Leidos Biomed) for the National Cancer Institute (NCI) under Prime Contract No. 75N91019D00024 & HHSN261201500003I, which provides Operations and Technical Support (OTS) for the FNLCR.
The Government assumes no liability for reimbursement for any effort or associated costs to respond, nor for any information provided as a result of this Special Notice as no information is being requested. Please be advised that any submissions provided, despite that no information is requested, become Government property and will not be returned, nor will there be any ensuing discussions or debriefings.
Responses submitted to this Special Notice are not offers and cannot be accepted by the U.S. Government to form a binding contract. It is the responsibility of the interested parties to monitor this site and any sites referenced herein for additional information pertaining to business opportunities with the FNLCR, if any.
Description of Work: Leidos Biomed is seeking a digital solution to support and modernize our current receiving processes. The project is referred to as the Receiving Process Improvement and Digital Transformation. The Scope of Work for the selected Vendor includes:
• Assessment and review of FNL/Leidos BioMed’s current receiving processes
• Design, Plan, Install and Configuration of software solutions to meet FNL/Leidos BioMed’s use cases and business processes and requirements.
• End User, System Administrator and System Owner Training
• Go-Live and Operational Support Services
Leidos Biomedical Research, Inc. Point of Contact for a copy of Solicitation/RFP No: S26-117:
Cody Wenner at cody.wenner@nih.gov
For information concerning other opportunities with the FNLCR, please refer to:
https://frederick.cancer.gov/workwithus/solicitations
Files
| File | Type | Posted |
|---|---|---|
| SAM Special Notice_S26-117 RP Improvement.pdf | ||
| S26-117 Request for Proposal.pdf |
Similar open opportunities
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity